Crossmark

Enhancing HCC Treatment: innovatively combining HDAC2 inhibitor with PD-1/PD-L1 inhibition

Published Online: 2023-09-16

Authors

Han, Rui http://orcid.org/0000-0001-8856-3681
Ling, Changquan

Wang, Yuqian

Lu, Lingeng
Funding

Funding for this research was provided by:

National Outstanding Youth Science Fund Project of National Natural Science Foundation of China (82204864)

Guangzhou Municipal Science and Technology Bureau (202201020252)
License Information

Text and Data Mining valid from 2023-09-16

Version of Record valid from 2023-09-16
More Information

Article History

Received: 30 June 2023

Accepted: 3 September 2023

First Online: 16 September 2023

Declarations

:

: The authors declare no competing interests.

: Not applicable.

Document is current